Abstract
Severe acute respiratory syndrome-associated coronavirus 2 (SARS-CoV-2) is an extremely pathogenic virus belonging to the family of Coronaviridae. First identified in Wuhan, China in December 2019 after an epidemiological investigation of an emerging cluster of pneumonia of unknown etiology, SARS-CoV-2 was declared the cause of a pandemic on March 11 by the World Health Organization (WHO), pointing to the over 118000 cases of Coronavirus disease 2019 (COVID-19) in over 110 countries. Despite the promising results of drug repositioning studies in the treatment of COVID-19, the evidence of their safety and efficacy remains inconclusive. Cell based therapy has been proven safe and possibly effective in treating multiple lung injuries and diseases, but its potential use in the treatment of COVID-19 has not been yet elucidated. Our aim in this review is to provide an overview of the immunomodulatory effect and the regenerative capacity of stem cells and their secretome in the treatment of many diseases including lung injuries. Those findings may contribute to a better understanding of the potential of stem cell therapy in SARS-CoV-2 infection and its potential use in order to find a solution for this healthcare crisis.
Keywords: Coronavirus, COVID-19, stem cells, cytokine storm, lung injuries, immunomodulatory effect.
Current Molecular Medicine
Title:Addressing the Importance of Stem Cell-Based Therapy: A Perspective in the Treatment of COVID-19
Volume: 21 Issue: 6
Author(s): Christine Ibrahim, Hanna Semaan, Marwan El-Sabban*, Fadia Najjar*Aline Hamade*
Affiliation:
- Department of Anatomy, Cell Biology and Physiological Sciences, Faculty of Medicine, American University of Beirut, Beirut,Lebanon
- Laboratoire d’Innovation Thérapeutique, Departments of Biology, Chemistry and Biochemistry, Lebanese University, Faculty of Sciences II, Fanar,Lebanon
- Laboratoire d’Innovation Thérapeutique, Departments of Biology, Chemistry and Biochemistry, Lebanese University, Faculty of Sciences II, Fanar,Lebanon
Keywords: Coronavirus, COVID-19, stem cells, cytokine storm, lung injuries, immunomodulatory effect.
Abstract: Severe acute respiratory syndrome-associated coronavirus 2 (SARS-CoV-2) is an extremely pathogenic virus belonging to the family of Coronaviridae. First identified in Wuhan, China in December 2019 after an epidemiological investigation of an emerging cluster of pneumonia of unknown etiology, SARS-CoV-2 was declared the cause of a pandemic on March 11 by the World Health Organization (WHO), pointing to the over 118000 cases of Coronavirus disease 2019 (COVID-19) in over 110 countries. Despite the promising results of drug repositioning studies in the treatment of COVID-19, the evidence of their safety and efficacy remains inconclusive. Cell based therapy has been proven safe and possibly effective in treating multiple lung injuries and diseases, but its potential use in the treatment of COVID-19 has not been yet elucidated. Our aim in this review is to provide an overview of the immunomodulatory effect and the regenerative capacity of stem cells and their secretome in the treatment of many diseases including lung injuries. Those findings may contribute to a better understanding of the potential of stem cell therapy in SARS-CoV-2 infection and its potential use in order to find a solution for this healthcare crisis.
Export Options
About this article
Cite this article as:
Ibrahim Christine , Semaan Hanna , El-Sabban Marwan *, Najjar Fadia *, Hamade Aline *, Addressing the Importance of Stem Cell-Based Therapy: A Perspective in the Treatment of COVID-19, Current Molecular Medicine 2021; 21 (6) . https://dx.doi.org/10.2174/1566524020999201117120147
DOI https://dx.doi.org/10.2174/1566524020999201117120147 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Competitive Interaction Between Plasma Omega-3 Fatty Acids and Arachidonic Acid is Related to Down-Regulation of A Signaling Mediator
Medicinal Chemistry An <i>In vivo</i> Immunohistochemical Study on MacroH2A.1 in Lung and Lymph-Node Tissues Exposed to an Asbestiform Fiber
Current Molecular Medicine Current Opinion in the Pharmaceutical Management of Irritable and Inflammatory Bowel Diseases: Role of ATP
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Can Lipoprotein-associated Phospholipase A<sub>2</sub> be Used as a Predictor of Long-term Outcome in Patients with Acute Coronary Syndrome?
Current Cardiology Reviews Blocking IL-6/GP130 Signaling Inhibits Cell Viability/Proliferation, Glycolysis, and Colony Forming Activity in Human Pancreatic Cancer Cells
Current Cancer Drug Targets Animal Models of Lung Fibrosis
Current Respiratory Medicine Reviews Role of Secretory Phospholipase A2 in CNS Inflammation: Implications in Traumatic Spinal Cord Injury
CNS & Neurological Disorders - Drug Targets Gene Therapy for Allergic Diseases
Current Gene Therapy Current Status and Future Perspectives of Chemoprevention in Head and Neck Cancer
Current Cancer Drug Targets Nanomedicines for Brain Targeting: A Patent Review
Recent Patents on Nanomedicine Crosstalk Between Histamine and T Cells in Allergic Diseases
Current Immunology Reviews (Discontinued) Direct-Acting Antivirals for Hepatitis C Virus (HCV): The Progress Continues
Current Drug Targets Patients with Hereditary Hemorrhagic Telangectasia (HHT) Exhibit a Deficit of Polymorphonuclear Cell and Monocyte Oxidative Burst and Phagocytosis: A Possible Correlation with Altered Adaptive Immune Responsiveness in HHT
Current Pharmaceutical Design Neutrophil Elastase as a Target in Lung Cancer
Anti-Cancer Agents in Medicinal Chemistry Recent Patents in Antiviral siRNAs
Recent Patents on Anti-Infective Drug Discovery Recent Advances in the Characterization of Genetic Factors Involved in Human Susceptibility to Infection by Schistosomiasis
Current Genomics Regulation and Function of Rankl in Arterial Calcification
Current Pharmaceutical Design Chemistry and Biology of Anti-Inflammatory Marine Natural Products. Phospholipase A2 Inhibitors
Current Organic Chemistry Monoclonal Antibody Therapy in Haematological Malignancies
Current Clinical Pharmacology Probing Heterotrimeric G Protein Activation: Applications to Biased Ligands
Current Pharmaceutical Design